Circulating tumor cells in head and neck cancer: A review
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures for early detection and disease aggressiveness....
Guardado en:
Autores principales: | Kyle P. McMullen, Jeffrey J. Chalmers, Jas C. Lang, Pawan Kumar, Kris R. Jatana |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30166729645c4ffa95d41eafaa81dd19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Moaz M. Choudhary, et al.
Publicado: (2016) -
Intra-tumor heterogeneity in head and neck cancer and its clinical implications
por: Edmund A. Mroz, et al.
Publicado: (2016) -
Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016) -
Novel therapeutics and emerging technologies in head and neck cancer
por: Theodoros N. Teknos, M.D.
Publicado: (2016) -
The current status of oncolytic viral therapy for head and neck cancer
por: Matthew O. Old, et al.
Publicado: (2016)